KR860002497A - Method for preparing a diaryl compound - Google Patents

Method for preparing a diaryl compound Download PDF

Info

Publication number
KR860002497A
KR860002497A KR1019850007105A KR850007105A KR860002497A KR 860002497 A KR860002497 A KR 860002497A KR 1019850007105 A KR1019850007105 A KR 1019850007105A KR 850007105 A KR850007105 A KR 850007105A KR 860002497 A KR860002497 A KR 860002497A
Authority
KR
South Korea
Prior art keywords
formula
acid derivative
alkyl
reacting
compound
Prior art date
Application number
KR1019850007105A
Other languages
Korean (ko)
Other versions
KR930001404B1 (en
Inventor
암슐러 헤르만
Original Assignee
빅굴덴 롬베르그 케미세파브리크 게젤샤프트 미트 베슈렝크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 빅굴덴 롬베르그 케미세파브리크 게젤샤프트 미트 베슈렝크터 하프퉁 filed Critical 빅굴덴 롬베르그 케미세파브리크 게젤샤프트 미트 베슈렝크터 하프퉁
Publication of KR860002497A publication Critical patent/KR860002497A/en
Application granted granted Critical
Publication of KR930001404B1 publication Critical patent/KR930001404B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음No content

Description

디아릴 화합물의 제조방법Method for preparing a diaryl compound

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (3)

일반식(Ⅱ)의 신남 산 유도체를 일반식(Ⅱ)의 엔아민 유도체와 반응시키거나; 일반식(Ⅱ)의 신남산 유도체를 암모니아 및 일반식(Ⅳ)의 β-케토카복실산 유도체와 반응시키거나; 일반식(Ⅴ)의 엔아민을 일반식(Ⅵ)의 벤질리덴 카복실산 유도체와 반응시키거나; 일반식(Ⅶ)의 케토 화합물을 암모니아 및 일반식 (Ⅵ)의 벤질리덴카복실산 유도체와 반응시키거나; 일반식(Ⅷ)의 알데하이드를 일반식(Ⅴ)의 엔아민 및 일반식(Ⅳ)의 β-케토카복실산 유도체와 반응시키거나; 일반식(Ⅷ)의 알데하이드를 일반식(Ⅲ)의 엔아민 유도체 및 일반식(Ⅶ)의 케토화합물과 반응시키거나; 일반식(Ⅸ)의 1,4-디하이드로피리딘을 일반식(Ⅹ)의 디아릴 화합물 그 자체와 또는 그의 염과 반응시키고; 경우에 따라, 생성된 염을 유리염기로 전환시키거나, 생성된 염기를 염으로 전환시킴을 특징으로하여, 일반식(Ⅰ)의 화합물 및 그의 염을 제조하는 방법.Reacting the cinnamic acid derivative of formula (II) with an enamine derivative of formula (II); The cinnamic acid derivative of formula (II) is reacted with ammonia and the β-ketocarboxylic acid derivative of formula (IV); Reacting the enamine of formula (V) with the benzylidene carboxylic acid derivative of formula (VI); Reacting the keto compound of formula (VII) with ammonia and the benzylidenecarboxylic acid derivative of formula (VI); Reacting an aldehyde of formula (VII) with an enamine of formula (V) and a β-ketocarboxylic acid derivative of formula (IV); Reacting an aldehyde of general formula (III) with an enamine derivative of general formula (III) and a keto compound of general formula (III); Reacting 1,4-dihydropyridine of formula (VII) with the diaryl compound of formula (IV) per se or with a salt thereof; Optionally a process for preparing a compound of formula (I) and salts thereof, characterized in that the resulting salt is converted to a free base or the resulting base is converted to a salt. 상기식에서, Ar은 일반식의 환을 나타내고; Y는 산소(O), 황(S), 비닐렌(-CH=CH-), 아조메틴(-CH=N-) 또는 구조식또는의 그룹을 나타내며;Wherein Ar is a general formula A ring of; Y is oxygen (O), sulfur (S), vinylene (-CH = CH-), azomethine (-CH = N-) or a structural formula or Represents a group of; R1,R2및,R3는 동일하거나 상이하며, 수소, (C1내지 C6)-알킬, (C3내지 C7)-알콕시알킬, 아릴, 아릴-(C1내지 C3)-알킬 또는 아릴옥시-(C1내지 C6)-알킬을 나타내고; R4및 R5는 동일하거나 상이하며; 수소, 하이드록실, 할로겐, 니트로, 시아노, 트리플루오로메틸, (C1내지 C4)-알킬, (C1내지 C4)-알콕시, 불소에 의해 완전히 또는 부분적으로 치환된 (C1내지 C4)-알콕시, (C1내지 C4)-알콕시카보닐, (C2내지 C5)-아실, 아미노 또는 모노-또는 디-(C1내지 C4)-알킬 아미노를 나타내고; R6,R7,R8및 R9는 동일하거나 상이하며, 수소, 하이드록실, 할로겐, (C1내지 C4)-알킬, (C1내지 C4)-알콕시, 아미노, 모노-또는 디-(C1내지 C4)-알킬 아미노, 또는 불소에 의해 완전히 또는 부분적으로 치환된(C1내지 C4)-알콕시를 나타내며; A는 (C1내지 C4)-알콕시 또는 아릴에 의해 치환될 수 있는 직쇄 또는 측쇄(C2내지 C5)-알킬렌을 나타내고; Z는, Z가 결합된 카보닐그룹과 함께, 카복실그룹 또는 반응성 카복실산 유도체를 나타낸다,R 1 , R 2 and R 3 are the same or different and are hydrogen, (C 1 to C 6 ) -alkyl, (C 3 to C 7 ) -alkoxyalkyl, aryl, aryl- (C 1 to C 3 )- Alkyl or aryloxy- (C 1 to C 6 ) -alkyl; R 4 and R 5 are the same or different; Completely or partially substituted by hydrogen, hydroxyl, halogen, nitro, cyano, trifluoromethyl, (C 1 to C 4 ) -alkyl, (C 1 to C 4 ) -alkoxy, fluorine (C 1 to C 4 ) -alkoxy, (C 1 to C 4 ) -alkoxycarbonyl, (C 2 to C 5 ) -acyl, amino or mono- or di- (C 1 to C 4 ) -alkyl amino; R 6 , R 7 , R 8 and R 9 are the same or different and are hydrogen, hydroxyl, halogen, (C 1 to C 4 ) -alkyl, (C 1 to C 4 ) -alkoxy, amino, mono- or di -(C 1 to C 4 ) -alkyl amino, or (C 1 to C 4 ) -alkoxy completely or partially substituted by fluorine; A represents a straight or branched chain (C 2 to C 5 ) -alkylene which may be substituted by (C 1 to C 4 ) -alkoxy or aryl; Z, together with the carbonyl group to which Z is bonded, represents a carboxyl group or a reactive carboxylic acid derivative, 제1항에 있어서, Ar이 2,1,3-벤즈옥스디아졸-4-일, 페닐, 2-니트로페닐, 3-니트로페닐, 2-시아노페닐, 3-시아노페닐, 2-(1,1,2,2-테트라플루오로-에톡시)-페닐, 3-(1,1,2,2-테트라플루오로-에톡시)-페닐, 2-디플루오로메톡시페닐, 3-디플루오로메톡시페닐, 2-클로로페닐, 3-클로로페닐,2,3-디클로로페닐,2-플루오로페닐,3-플루오로페닐, 2-트리플루오로메틸페틸 또는 3-트리플루오로메틸 페닐을 타나내괴 R1이 메틸을 나타내며; R2가 메틸을 나타내고; R3가 메틸, 에틸 또는 메톡시에틸을 나타내며; R6가 수소를 나타내고; R7이 수소 또는 메톡시를 나타내며; R8이 수소를 나타내고; R9가 수소 또는 메톡시를 나타내며; A가 에틸렌, 프로필렌, 부틸렌, 1,1-디메틸에틸렌 또는 2,2-디메틸에틸렌은 나타내는 방법.The compound of claim 1, wherein Ar is 2,1,3-benzoxdiazol-4-yl, phenyl, 2-nitrophenyl, 3-nitrophenyl, 2-cyanophenyl, 3-cyanophenyl, 2- ( 1,1,2,2-tetrafluoro-ethoxy) -phenyl, 3- (1,1,2,2-tetrafluoro-ethoxy) -phenyl, 2-difluoromethoxyphenyl, 3-di Fluoromethoxyphenyl, 2-chlorophenyl, 3-chlorophenyl, 2,3-dichlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 2-trifluoromethylpetyl or 3-trifluoromethyl phenyl Thana inner mass R 1 represents methyl; R 2 represents methyl; R 3 represents methyl, ethyl or methoxyethyl; R 6 represents hydrogen; R 7 represents hydrogen or methoxy; R 8 represents hydrogen; R 9 represents hydrogen or methoxy; A represents ethylene, propylene, butylene, 1,1-dimethylethylene or 2,2-dimethylethylene. 제1항에 있어서, 3-메틸-5-[3-(4,4-디페닐피페리드-1-일)-프로필]-1,4-디하이드로-2,6-디메틸-4-(3-니트로페닐)-피리딘-3,5-디카복실레이트 및 그의 염을 제조하는 방법.The compound of claim 1, wherein 3-methyl-5- [3- (4,4-diphenylpiperid-1-yl) -propyl] -1,4-dihydro-2,6-dimethyl-4- (3 -Nitrophenyl) -pyridine-3,5-dicarboxylate and salts thereof. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019850007105A 1984-09-28 1985-09-26 Process for preparing diaryl compounds KR930001404B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4652/84-8 1984-09-28
CH465284 1984-09-28

Publications (2)

Publication Number Publication Date
KR860002497A true KR860002497A (en) 1986-04-26
KR930001404B1 KR930001404B1 (en) 1993-02-27

Family

ID=4280111

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007105A KR930001404B1 (en) 1984-09-28 1985-09-26 Process for preparing diaryl compounds

Country Status (14)

Country Link
KR (1) KR930001404B1 (en)
AU (1) AU574842B2 (en)
CA (1) CA1291137C (en)
DK (1) DK440885A (en)
ES (3) ES8703148A1 (en)
FI (1) FI83957C (en)
GR (1) GR852364B (en)
HU (1) HU194210B (en)
IE (1) IE66677B1 (en)
IL (1) IL76511A (en)
NO (1) NO169586C (en)
NZ (1) NZ213629A (en)
PT (1) PT81209B (en)
ZA (1) ZA857477B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK704488D0 (en) * 1988-12-19 1988-12-19 Novo Industri As NEW N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS
DK142287A (en) * 1986-03-27 1987-09-28 Byk Gulden Lomberg Chem Fab OPTIC ACTIVE 1,4-DIHYDROPYRIDINE DERIVATIVES
HU206181B (en) * 1988-02-19 1992-09-28 Byk Gulden Lomberg Chem Fab Process for producing pharmaceutical compositions comprising optically pure r-(+)-niguldipin and its derivatives and suitable for treating tumoros diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI793848A (en) * 1978-12-18 1980-06-19 Sandoz Ag BENZOXADIAZOLER OCH BENZOTHIADIAZOLER DERAS FRAMSTAELLNING OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESSA

Also Published As

Publication number Publication date
PT81209A (en) 1985-10-01
FI853415L (en) 1986-03-29
CA1291137C (en) 1991-10-22
NZ213629A (en) 1989-07-27
IE852384L (en) 1986-03-28
AU4794885A (en) 1986-04-10
ES8703148A1 (en) 1987-02-16
AU574842B2 (en) 1988-07-14
PT81209B (en) 1988-01-22
NO853833L (en) 1986-04-01
DK440885D0 (en) 1985-09-27
HU194210B (en) 1988-01-28
ES8708135A1 (en) 1987-10-16
FI83957B (en) 1991-06-14
ES8800201A1 (en) 1987-11-01
ES547385A0 (en) 1987-02-16
NO169586C (en) 1992-07-15
GR852364B (en) 1985-12-13
IL76511A (en) 1990-06-10
NO169586B (en) 1992-04-06
DK440885A (en) 1986-03-29
ZA857477B (en) 1986-05-28
FI83957C (en) 1991-09-25
ES554068A0 (en) 1987-10-16
HUT38627A (en) 1986-06-30
IE66677B1 (en) 1996-01-24
FI853415A0 (en) 1985-09-06
ES554067A0 (en) 1987-11-01
KR930001404B1 (en) 1993-02-27

Similar Documents

Publication Publication Date Title
IE781234L (en) Isoxazolopyridines
KR860001796A (en) Method for preparing α-aryl-4- (4,5-dihydro-3,5-dioxo-1,2,4-triazine-2 (3H) -yl) benzeneacetonitrile
KR840006644A (en) 1,4-dihydropyridine derivative and preparation method
KR880012566A (en) Piperizine Derivatives
KR870000300A (en) Method for preparing new 1,4-dihydropyridine
KR860002497A (en) Method for preparing a diaryl compound
YU28500A (en) Process for the preparation of 1,4-dihydropyridines and compounds used in this process
IE41251B1 (en) New 1,4-dihydropyridines and processes for their manufacture
KR930701419A (en) Intermediates for the preparation of chelating agents having a predetermined symmetry and methods of making the same
IE42626L (en) 6-arylpyrroloimidazoles
ATE107288T1 (en) PROCESS FOR THE PREPARATION OF O-CARBOXYARYLIMIDAZOLINONES.
IE43984L (en) 1, 4-dihydropyridine-3. 5-dicarboxylic acid di-ester¹derivatives
KR860003244A (en) Oxazozolyl-1,4-dihydropyridine derivative and preparation method of acid addition thereof
GB1241637A (en) Improvements in or relating to anti-inflammatory compositions
IE781382L (en) Indole derivatives
KR840006222A (en) Process for preparing piperidine derivative
KR870000299A (en) Method for preparing 1,4-dihydropyridine derivative
KR840004724A (en) Method for preparing dihydropyridine and reaction intermediates thereof and pharmaceutical compositions thereof
KR870002135A (en) Method for preparing optically active, substituted 1,4-dihydropyridine
KR930016414A (en) Novel 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, their preparation methods and their use as medicaments
KR860004004A (en) Method for preparing 4-acyloxy-3-oxo-butyric acid ester
KR950017959A (en) Phenyl-substituted 1, 4-dihydropyridine
DK0578849T3 (en) Process for the preparation of 1,3-dioxane-4,6-dione derivatives
KR890005136A (en) Azetidinone N-phosphonomethyl ester
ES8706118A1 (en) 1,4-dihydropyridine derivative and production thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19960129

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee